Indore SEZ Exports Mein Kami, Pharma Shipments Ki Slowdown
Indore Special Economic Zone (SEZ) se exports mein thodi si kami dekhi gayi hai, pichle financial year mein 9.25% ki decline ke saath Rs 12,948 crore tak aa gayi hai. Yeh khabar Wednesday ko Union Ministry of Commerce and Industry ke ek official ne di.
Pharmaceuticals Ka Dhanda Slow, Exports Pe Effect
Indore SEZ, jismein kai tarah ke products ki factories hain, wahan se 2023-24 mein Rs 14,265.63 crore ka export hua tha. Official ne bataya ki Indore SEZ se hone wale exports mein kareeb 70% dawaiyon ka hissa hai, aur US in dawaiyon ka ek bada importer hai.
USFDA Approval Ki Kami, Exports Mein Rukaavat
Official ne PTI ko bataya, “2024-25 ke financial year mein, SEZ ke exports par USFDA se approval milne mein aa rahi dikkat ka asar pada hai. Indore SEZ ki ek badi dawai company ke kuch products ko USFDA ki approval nahi mil paayi. Iske alawa, SEZ ki kuch aur dawai companies ke international orders bhi kam ho gaye.”
Indore SEZ: Ek Manufacturing Hub
Pithampur industrial area mein 572 hectares mein phaila Indore SEZ, 59 plants ka ghar hai, jinmein dawai, packaging material, engineering, textile, aur food processing jaise sectors shamil hain. Inmein se 22 units sirf pharmaceutical sector se hain.
US: Generic Drugs Ka Bada Bazaar
Pithampur Industrial Organization ke President, Gautam Kothari ne kaha, “US, Indore SEZ mein banne wali generic drugs ka main importer hai.” Unhone aage kaha ki agar US aane wale dino mein India mein bani generic drugs par tariffs bhi lagata hai, toh bhi lambi race mein iska exports par zyada fark nahi padega.
Aage Kya?
Exports mein yeh kami chinta ka vishay hai. Dekhna hoga ki aane wale time mein kya hota hai aur kaise yeh situation sudharti hai. Government aur industries ko milkar is problem ka solution dhundhna hoga.
